NetworkNewsBreaks

MondaySep 27, 2021 1:09 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Eyes Commercial Plans to Become B2B Wholesale Supplier of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company based in British Columbia, Canada, is focused on advancing a pipeline of cannabinoid-based pharmaceutical drug candidates. The company is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn(TM), which is designed to advance rare and lesser-known cannabinoid production to commercial levels. A recent article discussing this quotes InMed CEO Eric A. Adams. “The next key milestone is to manufacture our first large-scale batch through a pharma-grade-ready process in the coming months. We will continue to optimize the process and scale up the IntegraSyn process into larger vessels,” Adams said in a recent…

Continue Reading

MondaySep 27, 2021 12:59 pm

NetworkNewsBreaks – MoneyShow’s October Virtual Expo Set to Showcase Key Market Insights, Trading Strategies

MoneyShow, a leading producer of financial conferences for affluent investors, active traders and financial advisors, today announced that it will host the upcoming MoneyShow Virtual Expo in an entirely digital format on Oct. 5-7, 2021. The event will shine the spotlight on some of the country’s most sought-after financial experts, who will assemble and share key insights about the markets along with the catalysts and trends driving them. The Virtual Expo is designed to arm conference attendees with the information and tools needed to help make them more successful investors or traders. This year’s event will feature a star-studded lineup of market…

Continue Reading

MondaySep 27, 2021 12:53 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes First Step in European Expansion Plan

Flora Growth Corp. (NASDAQ: FLGC) recently closed a €2 million investment in Hoshi International Inc., a fully integrated cannabis company, and uniquely positioned to become the leading provider of cannabis and derivative products for the budding European market. With the investment, Flora is set to capitalize on Hoshi’s strong European presence as well as leverage its technical know-how and understanding of its European market to not only expand its reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification. A recent article reads, “Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to…

Continue Reading

MondaySep 27, 2021 12:34 pm

NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Strategic Commercial Agreement with UK Licensee

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced its entry into a global commercial contract with MySugarWatch DuoPack Limited (“MSW-DP”). Under the agreement, the continuous glucose monitor (“CGM”) and sensors will be provided as duo packs with prescription only medicines that are widely prescribed for people with type 2 diabetes. MSW-DP has been granted global rights to the sugarBEAT(R) non-invasive CGM devices and sensors, to be provided solely as duo packs with these medicines, under the terms of the agreement, which Nemaura will…

Continue Reading

MondaySep 27, 2021 11:59 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Working to Bring Psychedelic Treatments Closer to the People

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is contributing to the ongoing conversation around the use of psychedelics in the field of medicine, thereby stamping its position as a leader in the psychedelic renaissance. This follows efforts by the scientific community in the 21st century to prove the potential of psychedelics to rewire or repair circuits in the brain. Specifically, Tryp is bringing light to psilocybin usage in diseases with high unmet needs, including chronic pain, through its Psilocybin-For Neuropsychiatric Disorders (TM) (“PFN”) program. “With its three strategic initiatives — develop, protect and monetize — Tryp remains committed to utilizing FDA’s…

Continue Reading

MondaySep 27, 2021 11:49 am

NetworkNewsBreaks – Hero Technologies (HENC) Announces Subsidiary Receive Key Approval for Cannabis Licenses

Hero Technologies (OTC: HENC), a cannabis company, and its subsidiary BlackBox Systems and Technologies LLC, has received step 1 prequalification approval for a class C adult-use cannabis license in the state of Michigan. The company also fulfilled the requirements for step 1 prequalification approval to receive a class C medicinal use cannabis license in Michigan. With these steps taken, the company now plans to start the process for step 2 establishment use or full license approval for a newly constructed medical marijuana facility. According to the announcement, once Hero Technologies completes step 2 with the Michigan Marijuana Regulatory Agency (“MRA”), it…

Continue Reading

MondaySep 27, 2021 11:47 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Spotlights Companies in Burgeoning EdTech Space at Inaugural Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, brought together some of the stars within the education technology (“EdTech”) market in the first-ever Sequire EdTech Conference. The event featured prominent virtual work and remote learning companies and touched multiple value points for SRAX by featuring a burgeoning industry as a key opinion leader, showing off its platform to potential clients and investors and spotlighting public companies in the EdTech space. With the fall season expected to again be challenging for schools following the prominence of the…

Continue Reading

MondaySep 27, 2021 11:09 am

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Refinances Approximately US$19M of Short-Term Debt

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced that it has completed a refinancing of an aggregate principal amount of US $18,620,000 debentures (plus accrued interest to Sept. 1, 2021) previously issued to an arm’s-length investor (collectively, the “prior debentures”). According to the update, the prior debentures were replaced with a new debenture in the principal amount of US $19,370,020. The unsecured new debenture bears interest at the rate of 10% per annum, which accrues and is payable on the maturity date of Jan. 21, 2023, and is…

Continue Reading

MondaySep 27, 2021 10:23 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Present in Two Upcoming Investor Conferences

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, will be participating in two upcoming investor conferences. The company announced that CEO Doug Drysdale will be presenting virtually in a fireside chat during the Cantor Virtual Global Healthcare Conference and, during the Benzinga Healthcare Small Cap Conference, Drysdale will be presenting and participating in a panel discussion. The Benzinga conference is scheduled for Thursday, Sept. 30, 2021, and Drysdale’s presentation is scheduled for 12:15 p.m. ET. According to the announcement, Drysdale will also be involved in a panel discussion titled “Addressing Mental Health through Emerging Therapies”…

Continue Reading

MondaySep 27, 2021 9:47 am

NetworkNewsBreaks – reAlpha CEO Discusses Regulation A “Mini IPOs” in Forbes Article

reAlpha CEO Giri Devanur authored a recent Forbes article titled “An Entrepreneur’s Guide To IPOs, SPACs And Regulation A.” Among other highlights, the article shines a light on the various routes business leaders can take on the path to capital formation, including through an initial public offering (“IPO”), merging with a special purpose acquisition company (“SPAC”), or through a Regulation A (Reg A) filing. Reg A is a form of equity crowdfunding that allows companies to raise money by offering shares to the general public, not just accredited investors. Reg A companies, like reAlpha, are quickly emerging as a go-to investment…

Continue Reading